Development of an in vitro blood-brain barrier model to study the effects of endosulfan on the permeability of tight junctions and a comparative study of the cytotoxic effects of endosulfan on rat and human glial and neuronal cell cultures

Environmental Toxicology

Volumn 21, Issue 3, 2006, Pages 223-235

  Chan, Melissa P L ^a   Morisawa, Shinsuke ^a   Nakayama, Aki ^a   Kawamoto, Yuko ^a   Yoneda, Minoru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Cytotoxicity; Endosulfan; Glial and neuronal cultures; Tight junctions

Indexed keywords

BLOOD; BRAIN; CELL CULTURE; MECHANICAL PERMEABILITY; SULFATE MINERALS; TOXICITY;

BLOOD-BRAIN BARRIER; CYTOTOXICITY; ENDOSULFAN; GLIAL AND NEURONAL CULTURES; TIGHT JUNCTIONS;

INSECTICIDES;

ALKADIENE; CARBON 14; CYCLOALKANE DERIVATIVE; ENDOSULFAN; ENDOSULFAN SULFATE; ORGANOCHLORINE INSECTICIDE; SULFATE; UNCLASSIFIED DRUG;

BLOOD; BRAIN; ENDOSULFAN; TOXICITY;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY TEST; ELECTRIC RESISTANCE; GLIA CELL; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PEST CONTROL; PRIORITY JOURNAL; RAT; SWINE; TIGHT JUNCTION;

ANIMALS; BLOOD-BRAIN BARRIER; CARBON RADIOISOTOPES; CELLS, CULTURED; ENDOSULFAN; HUMANS; INSECTICIDES; MODELS, BIOLOGICAL; NEUROGLIA; NEURONS; PERMEABILITY; RATS; TIME FACTORS;

GOSSYPIUM HIRSUTUM; SUIDAE;

EID: 33646814323     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20175     Document Type: Article

References (57)

1. Agrawal AK, Anand M, Zaidi NF, Seth PK. 1983. Involvement of serotonergic receptors in endosulfan neurotoxicity. Biochem Pharmacol 32:3591-3593.
2. Aleksandrowicz DR. 1979. Endosulfan poisoning and chronic brain syndrome. Arch Toxicol 43:65-68.
3. Anand M, Khanna RN, Gopal K, Gupta GS. 1980. Effect of endosulfan on bioelectrical activity of brain in rats. Vet Hum Toxicol 22:385-387.
4. Ansari RA, Siddiqui MKJ, Gupta PK. 1984. Toxicity of endosulfan: distribution of alpha- and beta-isomers of racemic endosulfan following oral administration in rats. Toxicol Lett 21:29-33.
5. [ATSDR] Agency for Toxic Substances and Disease Registry. 2000. Toxicological profile for endosulfan. U. S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
6. Blanco-Coronado JL, Repetto M, Ginestal RJ, Vicente JR, Yelamos F, Lardelli A. 1992. Acute intoxication by endosulfan. Clin Toxicol 30:575-583.
7. Boereboom FTJ, van Dijk A, van Zoonen P, Meulenbelt J. 1998. Nonaccidental endosulfan intoxication: a case report with toxicokinetic calculations and tissue concentrations. Clin Toxicol 36:345-352.
8. Boveri M, Berezowski V, Price A, Slupek S, Lenfant AM, Benaud C, Hartung T, Cecchelli R, Prieto P, Dehouck MP. 2005. Induction of blood-brain properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51:187-198.
9. Boyd EM, Dobos I. 1969. Protein deficiency and tolerated oral doses of endosulfan. Arch Int Pharmacodyn Ther 178:152-165.
10. Boyd EM, Dobos I, Krijnen CJ. 1970. Endosulfan toxicity and dietary protein. Arch Environ Health 21:15-19.
11. Brandt VA, Moon S, Ehlers J, Methner MM, Struttmann T. 2001. Exposure to endosulfan in farmers: two case studies. Am J Ind Med 39:643-649.
12. Castillo CG, Montante M, Dufour L, Martinez ML, Jiménez-Capdeville ME. 2002. Behavioral effects of exposure to endosulfan and methyl parathion in adult rats. Neurotoxicol Teratol 24:797-804.
13. Cecchelli R, Dehouck B, Descamps L, Fenart L, BuéE-Scherrer V, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP. 1999. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Delivery Rev 36:165-178.
14. Chan MPL, Mustafa AM, Hussein R, Hj Hussain S, Zulkifli SN, Abdullah AR. 2004. Pesticide residues in blood of schoolchildren from selected schools in peninsular Malaysia. Environ Health Focus 2(1):18-24.
15. 14C-endosulfan following single and repeated oral administration in male Sprague-Dawley rats. Environ Toxicol 20:533-541.
16. Coutselinis A, Kentarchou P, Boukis D. 1978. Concentration levels of endosulfan in biological material (report of three cases). For Sci 11:75.
17. Cucullo L, Hallene K, Dini G, Dal Taso R, Janigro D. 2004. Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier. Brain Res 997:147-151.
18. Deli MA, Abraham CS, Kataoka Y, Niwa M. 2005. Permeability studies on in vitro blood-brain barrier models: physiology, pathology and pharmacology. Cell Mol Neurobiol 20(1):59-127.
19. Demeter J, Heyndrickx A, Timperman J, Lefevere M, De Beer J. 1977. Toxicological analysis in a case of endosulfan suicide. Bull Environ Contam Toxicol 18:110-114.
20. Dikshith TSS, Raizada RB, Srivastava MK, Kaphalia BS. 1984. Response of rats to repeated oral administration of endosulfan. Ind Health 22:295-304.
21. [NIH] National Institute of Health, 2001. Chapter 4: In vitro methods for organ-specific toxicity. In: Report of the international workshop on in vitro methods for assessing acute systemic toxicity. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, Research Triangle Park, NC, p 61-88.
22. Ely TD, Macfarlane JF, Galen WP, Hine CH. 1967. Convulsions in thioden workers. A preliminary report. J Occup Med 9:35-37.
23. Eyer F, Felgenhauer N, Jetzinger E, Pfab R, Zilker TR. 2004. Acute endosulfan poisoning with cerebral edema and cardiac failure. J Toxicol Clin Toxicol 42:927-932.
24. Freed AL, Andus KL, Lunte SM. 2002. Investigation of substance P transport across the blood-brain barrier. Peptides 23:157-165.
25. Gaillard PJ, de Boer AG. 2000. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci 12:95-102.
26. Gonzales-Marisca L, Chavez de Ramirez B, Cereijido M. 1985. Tight junction formation in cultured epithelial cells (MDCK). J Membr Biol 86:113-121.
27. Gupta PK. 1978. Distribution of endosulfan in plasma and brain after repeated oral administration to rats. Toxicology 9:371-377.
28. Hayes WJ, Laws ER. 1991. Handbook of pesticide toxicology. San Diego, CA: Academic Press.
29. Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y, Nakagawa T, Mori M, Sawada N. 1999. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun 261:108-112.
30. Harry GJ, Billingsley M, Bruinik A, Campbell IL, Classen W, Dorman DC, Galli C, Ray D, Smith RA, Tilson HA. 1997. In vitro techniques for the assessment of neurotoxicity. Environ Health Perspect 106(suppl):131-158.
31. Jeliazkova-Mecheva VV, Bobilya DJ. 2003. A porcine astrocyte/ endothelial cell co-culture model of the blood-brain barrier. Brain Res Protoc 12:91-98.
32. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. 2005. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res 1064(1-2):21-31.
33. Lauer R, Bauer R, Linz B, Pittner F, Peschek GA, Ecker G, Friedl P, Noe CR. 2004. Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cells. Il Farmaco 59:133-137.
34. Lee HS, Namkoong K, Kim DH, Kim KJ, Cheong YH, Kim SS, Lee WB, Kim KY. 2004. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. Microvasc Res 68:231-238.
35. Lo RSK, Chan JCN, Cockram CS, Lai FMM. 1995. Acute tubular necrosis following endosulphan insecticide poisoning. Clin Toxicol 33:67-69.
36. Löscher W, Potschka H. 2005. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22-76.
37. Lu W, Tan YZ, Hu KL, Jiang XG. 2005. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm 295:247-260.
38. Madara JL. 1998. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60:121-142.
39. Megard I, Garrigues A, Orlowski S, Jorajuria S, Clayette P, Ezan E, Mabondzo A. 2002. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo&in vitro correlation. Brain Res 927:153-167.
40. Naqvi SM, Vaishnavi C. 1993. Mini review: bioaccumulative potential and toxicity of endosulfan insecticide to non-target animals. Comp Biochem Physiol 105:347-361.
41. Nath G, Datta KK, Dikshith TSS, Tandon SK, Pandya KP. 1978. Interaction of endosulfan and metepa in rats. Toxicology 11:385-393.
42. Pardridge WM. 1995. Blood-brain barrier biology and methodology. J Neuroviol 5:556-569.
43. Pardridge WM. 1995. Transport of small molecules through blood-brain barrier: biology and methodology. Adv Drug Delivery Rev 15:5-36.
44. Paul V, Balasubramaniam E, Kazi M. 1994. The neurobehavioural toxicity of endosulfan in rats: a serotogenergic involvement in learning impairment. Eur J Pharmacol 270:1-7.
45. Paul V, Balasubramaniam E, Jayakumar AR, Kazi M. 1995. A sex-related difference in the neurobehavioral and hepatic effects following chronic endosulfan treatment in rats. Eur J Pharmacol 293:355-360.
46. Raub TJ, Kuentzel SL, Sawada GA. 1992. Permeability of bovine microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. Exp Cell Res 199:330-340.
47. Rubin LL, Staddon JM. 1999. The cell biology of the blood-brain barrier. Annu Rev Neurosci 22:11-28.
48. Ohtsuki S. 2004. New aspects of the blood-brain barrier transporters: its physiological roles in the central nervous system. Biol Pharm Bull 27:1489-1496.
49. Seth PK, Zaidi NF, Agrawal AK, Anand M. 1986. Neurotoxicity of endosulfan in young and adult rats. Neurotoxicol 7:627-635.
50. Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JN, Malik AB. 1987. Molecular sieving characteristics of the cultured endothelial monolayers. J Cell Physiol 132:111-117.
51. Subramoniam A, Khanna VK, Mohindra J, Deth PK. 1994. Reduced phosphoinositide levels in endosulfan treated rat brain. Ind J Pharmacol 26:49-51.
52. Terziev G, Dimitrova N, Rusev F. 1974. Forensic medical and forensic chemical study of acute lethal poisinnins with Thiodan. Folia Med 16:325-329.
53. Tewes B, Franke H, Hellwig D, Decker S, Griesche D, Tilling T, Wegener J, Galla HJ. 1997. Preparation of endothelial cells in primary cultures obtained from the brains of 6-month-old pigs. In: de Boer AG, editor. Drug transport across the blood-brain barrier. Australia: Harwood Academic Publishers, Amsterdam, The Netherlands. p 91-97.
54. van der Sandt ICJ, Smolders R, Nabulsi L, Zuideveld KP, de Boer AG, Breimer DD. 2001. Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. Eur J Pharm Sci 14:81-86.
55. Walnum E, Hansson E, Harvey AL. 1990. In vitro testing of neurotoxicity. ATLA 18:153-179.
56. Yoo JW, Kim YS, Lee SH, Lee MK, Roh HJ, Jhun BH, Lee CH, Kim DD. 2003. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Pharm Res 20:1690-1696.
57. Zaidi NF, Agrawal AK, Anand M, Seth PK. 1985. Neonatal endosulfan neurotoxicity: behavioral and biochemical changes in rat pups. Neurobehav Toxicol Teratol 7:439-442.